These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34775469)

  • 1. Emerging role of G9a in cancer stemness and promises as a therapeutic target.
    Haebe JR; Bergin CJ; Sandouka T; Benoit YD
    Oncogenesis; 2021 Nov; 10(11):76. PubMed ID: 34775469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel small molecule inhibitors of lysine methyltransferase G9a and their mechanism in leukemia cell lines.
    Kondengaden SM; Luo LF; Huang K; Zhu M; Zang L; Bataba E; Wang R; Luo C; Wang B; Li KK; Wang PG
    Eur J Med Chem; 2016 Oct; 122():382-393. PubMed ID: 27393948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors.
    Bergin CJ; Zouggar A; Mendes da Silva A; Fenouil T; Haebe JR; Masibag AN; Agrawal G; Shah MS; Sandouka T; Tiberi M; Auer RC; Ardolino M; Benoit YD
    Nat Cancer; 2024 Mar; 5(3):463-480. PubMed ID: 38351181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
    Bergin CJ; Zouggar A; Haebe JR; Masibag AN; Desrochers FM; Reilley SY; Agrawal G; Benoit YD
    Oncogene; 2021 Feb; 40(6):1191-1202. PubMed ID: 33323965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer.
    Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ
    Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
    Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
    Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma.
    Bhat AV; Palanichamy Kala M; Rao VK; Pignata L; Lim HJ; Suriyamurthy S; Chang KT; Lee VK; Guccione E; Taneja R
    Cancer Res; 2019 May; 79(9):2232-2243. PubMed ID: 30833420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The methyltransferase G9a regulates HoxA9-dependent transcription in AML.
    Lehnertz B; Pabst C; Su L; Miller M; Liu F; Yi L; Zhang R; Krosl J; Yung E; Kirschner J; Rosten P; Underhill TM; Jin J; Hébert J; Sauvageau G; Humphries RK; Rossi FM
    Genes Dev; 2014 Feb; 28(4):317-27. PubMed ID: 24532712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma.
    Colyn L; Bárcena-Varela M; Álvarez-Sola G; Latasa MU; Uriarte I; Santamaría E; Herranz JM; Santos-Laso A; Arechederra M; Ruiz de Gauna M; Aspichueta P; Canale M; Casadei-Gardini A; Francesconi M; Carotti S; Morini S; Nelson LJ; Iraburu MJ; Chen C; Sangro B; Marin JJG; Martinez-Chantar ML; Banales JM; Arnes-Benito R; Huch M; Patino JM; Dar AA; Nosrati M; Oyarzábal J; Prósper F; Urman J; Cubero FJ; Trautwein C; Berasain C; Fernandez-Barrena MG; Avila MA
    Hepatology; 2021 Jun; 73(6):2380-2396. PubMed ID: 33222246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting EHMT2/ G9a for cancer therapy: Progress and perspective.
    Jan S; Dar MI; Wani R; Sandey J; Mushtaq I; Lateef S; Syed SH
    Eur J Pharmacol; 2021 Feb; 893():173827. PubMed ID: 33347828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia.
    Pappano WN; Guo J; He Y; Ferguson D; Jagadeeswaran S; Osterling DJ; Gao W; Spence JK; Pliushchev M; Sweis RF; Buchanan FG; Michaelides MR; Shoemaker AR; Tse C; Chiang GG
    PLoS One; 2015; 10(7):e0131716. PubMed ID: 26147105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
    Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
    Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors.
    Souza BK; Freire NH; Jaeger M; de Farias CB; Brunetto AL; Brunetto AT; Roesler R
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a.
    Poulard C; Noureddine LM; Pruvost L; Le Romancer M
    Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism.
    Fang S; Miao J; Xiang L; Ponugoti B; Treuter E; Kemper JK
    Mol Cell Biol; 2007 Feb; 27(4):1407-24. PubMed ID: 17145766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis.
    Kato H; Tateishi K; Fujiwara H; Ijichi H; Yamamoto K; Nakatsuka T; Kakiuchi M; Sano M; Kudo Y; Hayakawa Y; Nakagawa H; Tanaka Y; Otsuka M; Hirata Y; Tachibana M; Shinkai Y; Koike K
    Cancer Genomics Proteomics; 2020; 17(6):695-705. PubMed ID: 33099471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
    Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G9a - An Appealing Antineoplastic Target.
    Chen WL; Sun HP; Li DD; Wang ZH; You QD; Guo XK
    Curr Cancer Drug Targets; 2017; 17(6):555-568. PubMed ID: 27174055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response.
    Luo CW; Wang JY; Hung WC; Peng G; Tsai YL; Chang TM; Chai CY; Lin CH; Pan MR
    Radiother Oncol; 2017 Sep; 124(3):395-402. PubMed ID: 28351524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.